Bioactivity:

Regadenoson is an adenosine derivative and selective A2A adenosine receptor agonist with coronary vasodilating activity. Upon administration, regadenoson selectively binds to and activates the A2A adenosine receptor, which induces coronary vasodilation. T

CAS nr:

313348-27-5

Purity:

98%

Molecular Weight:

390,35

SMILES:

n1(ncc(c1)C(=O)NC)c1nc2n(cnc2c(n1)N)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)CO

Formula:

C15H18N8O5

Pathway:

Neuroscience,GPCR/G Protein

Target:

Adenosine Receptor,Adenosine Receptor